Organon (OGN) stock jumps as reports say Sun Pharma made a $12B binding offer for the company after completing due diligence.

Best Medicine is about to wrap up its first season — but Abigail Spencer already has hopes for season 2. “[Executive producer ...

The last time I wrote an article on Eledon Pharmaceuticals, Inc. (ELDN) it was with respect to a Seeking Alpha article entitled "Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart ...

Ah, St. Patrick’s Day is upon us — a fine time to restore our sense of humor. More than 20 years ago, British sociologist Christie Davies wrote in “The Mirth of Nations” that Americans were becoming ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: ...

JERUSALEM, Jan 28 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported strong quarterly results on Wednesday but forecast lower net profit and revenue in 2026 on a more than $1 ...

I have two sons still living at home. In brotherly exchanges, Jack, 14, is quite funny, but his mouth occasionally writes checks that his body can’t cash, for Finn, 16, has height and weight on him.

Despite its strength in pharmaceuticals and biotechnology, the United States faces manufacturing challenges, including dependence on China for key inputs, which the National Security Commission on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A South Carolina pharmaceutical ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Watch in our video player above. Pharmaceutical companies Amgen, ...